Research-grade peptides, independently verified.
Each compound is third-party tested for identity and purity, with a certificate of analysis available for every lot. Shipped cold-chain from accredited facilities in the EU and US.
Stable gastric pentadecapeptide studied for tissue repair pathways.
Synthetic fragment of Thymosin β4; investigated for cellular migration.
28‑amino‑acid peptide investigated for T‑cell maturation and immune modulation.
Zinc‑bound nonapeptide explored in thymic immune regulation studies.
α‑MSH C‑terminal tripeptide studied for anti‑inflammatory signaling.
Cathelicidin‑derived antimicrobial peptide studied in host defense research.
Octapeptide investigated as a tight‑junction regulator in intestinal models.
Arginate salt form of BPC‑157 studied for enhanced stability in repair models.
Vasoactive intestinal peptide explored for immunomodulatory pathways.
Copper tripeptide complex studied in dermal remodeling research.
Native copper‑binding tripeptide investigated in regenerative pathways.
Tetrapeptide studied for telomerase activity in cellular models.
Mitochondrial‑derived 24‑aa peptide investigated in cytoprotection studies.
16‑aa mitochondrial peptide studied in metabolic and aging research.
Mitochondria‑targeted tetrapeptide investigated for cardiolipin stabilization.
Khavinson thymic bioregulator studied for immune senescence pathways.
Tripeptide bioregulator investigated for neuronal protection in aged models.
Vascular bioregulator tripeptide explored in endothelial research.
D‑retro inverso peptide investigated for senescent‑cell clearance research.
ACTH(4‑10) analog explored for neurotrophic signaling.
N‑terminally acetylated Semax investigated for extended stability.
Heptapeptide investigated for anxiolytic and immunomodulatory effects.
Acetylated Selank analog studied for prolonged neuro‑modulatory effects.
Hexapeptide investigated as a hepatocyte growth factor mimetic in CNS models.
Synthetic peptide derived from CNTF studied in neurogenesis research.
Neuropeptide preparation investigated in cognitive recovery research.
Spadin analog investigated for TREK‑1 channel modulation in mood research.
Delta sleep‑inducing peptide studied for sleep architecture pathways.
NCAM‑derived peptide investigated for synaptic plasticity in CNS models.
Long‑acting GHRH analog used in growth axis research.
Mod GRF(1‑29) studied for pulsatile GHRH stimulation research.
GHRH(1‑29) fragment investigated in pulsatile growth hormone studies.
Stabilized GHRH analog studied for visceral adiposity endpoints.
Selective ghrelin receptor agonist investigated in pulsatile GH release.
Synthetic hexapeptide GHRP studied in growth hormone secretion research.
Growth hormone‑releasing hexapeptide investigated in endocrine models.
Enkephalin‑derived hexapeptide studied for ghrelin receptor activation.
Modified hGH fragment(176‑191) studied for lipolytic activity.
C‑terminal hGH fragment investigated for adipose tissue research.
Non‑peptide ghrelin mimetic studied for sustained GH/IGF‑1 elevation.
Long R3 IGF‑1 analog studied for prolonged receptor binding.
Truncated IGF‑1 variant investigated for localized tissue response.
GLP‑1 receptor agonist analog studied in glycemic and weight research.
Dual GIP/GLP‑1 receptor agonist investigated in metabolic studies.
Triple GIP/GLP‑1/glucagon receptor agonist investigated in obesity research.
Small‑molecule NNMT inhibitor studied for adipocyte metabolism research.
ERR pan‑agonist investigated for oxidative metabolism in muscle models.
α‑MSH analog studied in pigmentation pathway research.
α‑MSH analog studied in melanogenesis research.
Cyclic melanocortin analog investigated for central arousal pathways.
Decapeptide studied for GnRH neuron activation and HPG‑axis signaling.
Synthetic GnRH decapeptide investigated for LH/FSH release research.
Nonapeptide neurohormone investigated in social bonding and lactation studies.
Looking for a custom synthesis?
We routinely produce non‑catalog peptides on request — typical turnaround is 3–4 weeks.
Request a quote